| ã€Objective】The purpose of this study was to detect gene mutation in Truncated middle surfaceprotein (MHBst)of patients with HCCã€HBC and CHB, make sure the types of MHBstgene mutation in HCC patients, explore mechanism of the HCC occurrence anddevelopment and its significance, and design a simple laboratory method for thedetected of MHBstgene mutation.ã€Methods】Genomic DNA was extracted from plasma sample of96patients with HCCã€40patients with HBC and51patients with CHB respectively. MHBstgene was amplifiedby polymerase chain reaction (PCR), followed by DNA sequencing to detect genemutation; compare the rate of MHBstgene mutation between HCC group andnon-HCC (HBCã€CHB) group in peripheral blood; compare the correlation betweenMHBstgene status and clinical pathological characteristic〠NF-κB in HCC group;The detected gene mutation was further tested by TaqMan-MGB probe-basedreal-time fluorescent quantitative PCR.ã€Results】1.Two MHBstgene mutations out of187patients were identified, which novel pointmutation was MHBst165(C>A) and reported point mutations was MHBst78(G>T)respectively.2.Compared with non-HCC group, HCC group(55/96,57.3%) have a higher rate ofMHBstgene mutation than the non-HCC group(37/91,40.7%)P=0.023;There wereno significant correlation between MHBstgene mutation and clinical pathologicalcharacteristic in cases with HCC, The expression of NF-κB in HCC cases with MHBstgene mutation was higher than that in cases without MHBstgene mutation in HCCtissue. 4.TaqMan-MGB probe method was successfully designed to detect point mutationMHBst165(C>A).ã€Conclusions】1. A novel point mutation MHBst165(C>A)was found in our research.2.The positive rate of MHBstof gene mutation is higher in patients with HCC.MHBstmight have a function of transactivation in patients with HCC through up-regualtingthe expression of NF-κB.3.TaqMan-MGB probe assay might contribute to mass screening of MHBst165(C>A)with its easy and quick operation. |